Diskus inhaler

DEVICE2 trials

Sponsors

GlaxoSmithKline, Orion Corporation, Orion Pharma

Conditions

AsthmaChronic Obstructive Pulmonary DiseasePulmonary Disease, Chronic Obstructive

Phase 4

Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.

CompletedNCT00355342

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2004-04-28End: 2007-09-06Updated: 2018-07-02

Unknown Phase

Inspiratory Flow Parameters of Easyhaler and Diskus Inhalers (SALIF)

CompletedNCT01424137

Orion Corporation, Orion PharmaAsthma, Chronic Obstructive Pulmonary Disease

Start: 2011-09-30End: 2011-11-30Updated: 2012-02-03

Related Papers

Successful Use of Easyhaler<sup>®</sup> Dry Powder Inhaler in Patients with Chronic Obstructive Pulmonary Disease; Analysis of Peak Inspiratory Flow from Three Clinical Trials.

2024-01-031 citations

Patients with asthma or chronic obstructive pulmonary disease (COPD) can generate sufficient inspiratory flows via Easyhaler<sup>®</sup> dry powder inhaler: a pooled analysis of two randomized controlled trials.

2021-02-017 citations

Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysis.

2020-01-0620 citations